US 11,879,140 B2
P21 mRNA targeting DNAzymes
Noam Pilpel, Rehovot (IL); Yossi Ovadya, Rehovot (IL); Dina Raichlin, Rehovot (IL); Etti Katz-Kadosh, Rehovot (IL); Alaa Knany, Rehovot (IL); Ella Gillis, Rehovot (IL); Noam Borovsky, Rehovot (IL); Anastasia Shapiro, Rehovot (IL); and Ido Bachelet, Rehovot (IL)
Assigned to 1E THERAPEUTICS LTD., Rehovot (IL)
Filed by 1E Therapeutics Ltd., Rehovot (IL)
Filed on Jun. 28, 2023, as Appl. No. 18/342,853.
Application 18/342,853 is a continuation of application No. PCT/IL2021/051546, filed on Dec. 28, 2021.
Claims priority of provisional application 63/130,937, filed on Dec. 28, 2020.
Prior Publication US 2023/0365952 A1, Nov. 16, 2023
Int. Cl. C12N 9/22 (2006.01); A61P 13/12 (2006.01)
CPC C12N 9/22 (2013.01) [A61P 13/12 (2018.01)] 24 Claims
1. A DNAzyme molecule comprising the nucleic acid sequence as set forth in SEQ ID NO: 54.